Canadian CANNAINVESTOR Magazine July / August 2017 | Page 20

Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. Cannabinoids are poorly absorbed by the body’s gastrointestinal tract and consumers often default to alternate routes of administration like smoking to achieve higher effectiveness.

Our process changes the way edible

cannabinoids enter the body:

1) Masks taste

-Eliminates the need for sugar-filled edibles.

2) Reduces the time of onset

-THC effects are felt within 15-20 min (vs. 60-120 min).

3) Increased bio-absorption: 5-10X

-Equates absorption by inhalation.

Patented for Cannabidiol

(CBD) and all other nonpsychoactive

cannabinoids

Patent-pending for THC

and psychoactive

cannabinoids.

Lexaria is a bioscience technology disruptor for edible cannabinoids.

20